Chronic neutropenia and human immunodeficiency virus infection

Authors

  • Ronald Noguera Valverde Caja Costarricense de Seguro Social, Hospital "Dr. Max Peralta Jiménez"
  • Ricardo Boza Cordero Caja Costarricense del Seguro Social, Hospital San Juan de Dios

DOI:

https://doi.org/10.51481/amc.v50i3.384

Keywords:

Chronic neutropenia, high activity antiretroviral therapy, HIV infection, granulocyte-colony stimulant factors, adverse effects

Abstract

A case of a male with chronic neutropenia and human immunodeficiency virus infection is presented along, with a review of possible pathogenic mechanisms. Hematological abnormalities as anemia, thrombocytopenia and leucopenia are frequently associated with acute human immunodeficiency virus infection. As antiretroviral therapy establishes and viral activity diminishes, hematological disturbances improve. However, some antiretroviral drugs, e.g., zidovudine, exhibits medullary toxicity and it can worsen the hematological findings in these patients, forcing subsequent changes on therapeutic schemes. Cytotoxics used in associated neoplasms have known antimedullary activity. Some antimicrobial agents like trimethoprimsulfamethoxazole, used prophylactically, also exhibit medullary toxicity, because of this, they should be used with caution or should be avoided.

Finally, other mechanisms which can cause neutropenia are enlisted: formation of anti-neutrophiles antibodies, primary damage of granulocyte progenitor, imbalance of neutrophil production, antibodies against gp120 viral envelope glycoprotein, or vitamins deficiencies. The approach of the neutropenic febrile patient in whom severe bacterial infection is suspected, includes the use of granulocyte-colonies stimulating factors in order to increase the absolute neutrophil count and to achieve a better clinical outcome.

Downloads

Download data is not yet available.

References

Meynard JL, Guiguet M, Arsac S, Frottier J, Meyohas MC. Frecuency and risk factors of infectious complications in neutropenic patients infected with HIV. AIDS 1997;11:995-998.

Hsieh MM, Everhart JE, Byrd-Holt D, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status and ethnic differences. Ann Intern Med 2007;146:486-492.Ibáñez L, Vidal X, Ballarín E, Laporte JR. Population-based druginduced agranulocytosis Arch Intern Med. 2005;165:869-874.

Moses A, Nelson J, Bagby GC. The influence of human immunodeficiency virus-1 on hematopoyesis. Blood 1998;91:14791495.

Góngora-Biachi R, Castro-Sansores C. Complicaciones sistémicas de la infección por el VIH y el sida. En: Góngora-Biachi R, editor. VIH y Sida: un enfoque a 25 años de su emergencia. Mérida: Ediciones del Grupo de Estudios de VIH/Sida del Sureste, 2006:155-169.

Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449-70.

Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1965-1970.

Moore D, Benepal T, Portsmouth S, Gill J, Gazzard B. Etiology and natural history of neutropenia in HIV disease: a prospective study. Clin Infect Dis 2001;32:469-476.

Levine AM, Karim R, Mack W, Gravnink J, Anastos K, Young M, et al. Neutropenia in human inmunodeficiency infection. Arch Intern Med 2006;166:405-410.

Nielsen SD, Ersboll AK, Mathiesen L, Nielsen JO, Hansen JES. Highly active antiretroviral therapy normalizes the function of progenitor cells in HIV-infected patients. J Infect Dis 1998;178:12991305.

Kuritzkes D. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with HIV disease: the role of granulocyte colonystimulating factor. Clin Infect Dis 2000;30:256-260.

Aprikyan AG, Liles WC, Dale DC. Emerging role of apoptosis in the pathogenesis of severe neutropenia. Curr Opin Hematol 2000;7:131132.

Downloads

Published

2008-07-01

How to Cite

Chronic neutropenia and human immunodeficiency virus infection. (2008). Acta Médica Costarricense , 50(3), 175-177. https://doi.org/10.51481/amc.v50i3.384